Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Treadmill Exercise in Metabolic Syndrome

Not Applicable

Terminated

Conditions: Metabolic Syndrome

Interventions: Other: Treadmill Exercise- traditional approach
Other: Treadmill Exercise- behavioral approach

First Posted Date: 2018-02-19

Last Posted Date: 2022-05-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 12

Registration Number: NCT03435315

Locations: 🇺🇸
BIDMC, Boston, Massachusetts, United States

IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3

Phase 2

Completed

Conditions: Small Fiber Neuropathy
Idiopathic Peripheral Neuropathy

Interventions: Drug: Intravenous immunoglobulin
Drug: 0.9% Sodium Chloride

First Posted Date: 2018-01-17

Last Posted Date: 2023-09-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT03401073

Locations: 🇺🇸
Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States

Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

Phase 2

Completed

Conditions: Septic Shock
Sepsis
Metabolic Disturbance

Interventions: Drug: vitamin C, vitamin B1, hydrocortisone
Drug: Normal saline

First Posted Date: 2018-01-03

Last Posted Date: 2021-02-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 205

Registration Number: NCT03389555

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Mount Auburn Hospital, Cambridge, Massachusetts, United States

and more 10 locations

Sleep and Inflammatory Resolution Pathway

Early Phase 1

Active, not recruiting

Conditions: Inflammatory Response
Sleep Restriction
Inflammation
Sleep

Interventions: Drug: Placebo
Drug: Aspirin

First Posted Date: 2017-12-19

Last Posted Date: 2025-03-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 66

Registration Number: NCT03377543

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

Not Applicable

Completed

Conditions: Shivering
Nausea and Vomiting, Postoperative

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2017-12-12

Last Posted Date: 2021-10-01

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 100

Registration Number: NCT03370562

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

House Calls and Peer Mentorship

Not Applicable

Completed

Conditions: Chronic Kidney Disease
End-Stage Renal Disease

Interventions: Behavioral: House Call
Behavioral: Peer Mentorship

First Posted Date: 2017-11-28

Last Posted Date: 2024-03-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 320

Registration Number: NCT03354910

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients

Completed

Conditions: Critical Illness
Sarcopenia
Muscle Weakness
Stroke, Acute

First Posted Date: 2017-11-20

Last Posted Date: 2024-08-20

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 164

Registration Number: NCT03347656

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇩🇪
Klinikum rechts der Isar of Technische Universität München, Munich, Bavaria, Germany
🇺🇸
Beth Israel Deconess Medical Center, Boston, Massachusetts, United States

Olaparib in Metastatic Breast Cancer

Phase 2

Active, not recruiting

Conditions: Metastatic Breast Cancer
Invasive Breast Cancer
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
CHEK2 Gene Mutation
ATM Gene Mutation
PALB2 Gene Mutation
RAD51 Gene Mutation
BRIP1 Gene Mutation
NBN Gene Mutation

Interventions: Drug: Olaparib

First Posted Date: 2017-11-17

Last Posted Date: 2025-03-17

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 114

Registration Number: NCT03344965

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

and more 17 locations

2-stage Cervical Cancer Screening in Botswana

Not Applicable

Completed

Conditions: HIV/AIDS
Cervical Cancer

Interventions: Diagnostic Test: 2-stage screen

First Posted Date: 2017-10-27

Last Posted Date: 2020-05-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 239

Registration Number: NCT03324009

Locations: 🇧🇼
Princess Marina Hospital, Gaborone, Botswana

Measuring Skin Elasticity in Lymphedema Patients

Not Applicable

Terminated

Conditions: Diagnoses Disease
Lymphedema

Interventions: Device: Lymphedema Indentometer

First Posted Date: 2017-10-19

Last Posted Date: 2025-06-04

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 7

Registration Number: NCT03313999

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy